---
title: "Synthesis: End-to-End Integrated In Silico Oncogenomics Pipeline"
type: synthesis
created: 2026-08-17
updated: 2026-08-17
tags:
  - oncology
  - transcriptomics
  - systems-biology
  - clinical-genomics
  - synthesis
aliases:
  - Integrated Oncogenomics Pipeline
sources:
  - "[[wiki/summaries/integrated-bioinformatics-analysis-roadmap]]"
  - "[[wiki/summaries/bioinformatics-research-journal]]"
---

# Synthesis: End-to-End Integrated In Silico Oncogenomics Pipeline

Secondary multi-omics analysis transforms publicly archived patient datasets into novel prognostic biomarkers, therapeutic targets, and immunological insights without requiring physical wet-lab experimentation.

```mermaid
graph TD
    subgraph Data["1. Cohort Ingestion"]
        GEO["GEO / TCGA (RNA-Seq Count Matrices)"]
    end
    
    subgraph DGE["2. Statistical Modeling"]
        DESeq["DESeq2 Negative Binomial Shrinkage (padj < 0.05, |log2FC| > 1.5)"]
    end
    
    subgraph Pathway["3. Functional Profiling"]
        Enrich["DAVID / KEGG / Gene Ontology Overrepresentation"]
    end
    
    subgraph Systems["4. Systems Interrogation"]
        STRING["STRING Database Interactome"]
        Cyto["Cytoscape (CytoHubba MCC / MCODE Complexes)"]
        STRING --> Cyto
    end
    
    subgraph Clinical["5. Clinical Translation"]
        KM["Kaplan-Meier Overall Survival (Log-Rank p < 0.05)"]
        Deconv["CIBERSORT Immune Infiltration"]
    end
    
    Data --> DGE --> Pathway --> Systems --> Clinical
```

## Step-by-Step Rigor Criteria

1. **Cohort Preprocessing & Normalization**:
   - Filter low-count transcripts ($\text{rowSums} \ge 10$) across clinical replicates to eliminate Poisson noise artifacts.
   - Employ [[Differential-Gene-Expression-DESeq2]] dispersion shrinkage to mitigate false discovery rates on small sample sizes ($n < 20$).
2. **Topological Interactome Pruning**:
   - Rather than treating all differentially expressed genes (DEGs) equally, map DEGs onto physical protein-protein interaction networks ([[STRING-Database]]).
   - Apply Maximal Clique Centrality (MCC) in [[Cytoscape]] to isolate the **top 10 bottleneck hub regulators** driving cell cycle deregulation or oncogenic signaling.
3. **Clinical Survival & Microenvironment Prognosis**:
   - Validate that elevated hub gene expression directly stratifies patient mortality in [[Kaplan-Meier-Survival-Analysis]].
   - Dissect tumor microenvironment immune composition using [[Tumor-Immune-Infiltration]] (e.g. CIBERSORTx) to evaluate tumor immunogenicity and potential immunotherapy sensitivity.

## Related Entities & Concepts
- [[GEO-TCGA]]
- [[DESeq2]]
- [[STRING-Database]]
- [[Cytoscape]]
- [[Protein-Protein-Interaction-Networks]]
- [[Kaplan-Meier-Survival-Analysis]]
- [[Tumor-Immune-Infiltration]]
- [[TP53]]
